CLOMID Drug Patent Profile
✉ Email this page to a colleague
When do Clomid patents expire, and when can generic versions of Clomid launch?
Clomid is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in CLOMID is clomiphene citrate. There are sixteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the clomiphene citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clomid
A generic version of CLOMID was approved as clomiphene citrate by COSETTE on August 30th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CLOMID?
- What are the global sales for CLOMID?
- What is Average Wholesale Price for CLOMID?
Summary for CLOMID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 166 |
| Clinical Trials: | 53 |
| Patent Applications: | 562 |
| Drug Prices: | Drug price information for CLOMID |
| DailyMed Link: | CLOMID at DailyMed |
Recent Clinical Trials for CLOMID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ain Shams University | Phase 1/Phase 2 |
| rana alaaeldin aly ibrahim nasr | Phase 1/Phase 2 |
| Yale University | Phase 1 |
US Patents and Regulatory Information for CLOMID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | CLOMID | clomiphene citrate | TABLET;ORAL | 016131-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
